278 related articles for article (PubMed ID: 11838856)
41. Evaluation of vascular injury with proinflammatory cytokines, thrombomodulin and fibronectin in patients with primary fibromyalgia.
Pay S; Calgüneri M; Calişkaner Z; Dinç A; Apraş S; Ertenli I; Kiraz S; Cobankara V
Nagoya J Med Sci; 2000 Nov; 63(3-4):115-22. PubMed ID: 11201985
[TBL] [Abstract][Full Text] [Related]
42. Plasma levels of interleukin-6, interleukin-10, and interleukin-1 receptor antagonist in depression: comparison between the acute state and after remission.
Kubera M; Kenis G; Bosmans E; Zieba A; Dudek D; Nowak G; Maes M
Pol J Pharmacol; 2000; 52(3):237-41. PubMed ID: 11055582
[TBL] [Abstract][Full Text] [Related]
43. Correlation between cytokines and anxious-depressive symptoms in patients with fibromyalgia.
García-Lozano JR; Capilla-Sevilla C; García-López O; Moreno-Gallego I
Reumatol Clin; 2008 Jul; 4(4):136-9. PubMed ID: 21794519
[TBL] [Abstract][Full Text] [Related]
44. Pain and pain relief in fibromyalgia patients followed for three years.
Pöyhiä R; Da Costa D; Fitzcharles MA
Arthritis Rheum; 2001 Aug; 45(4):355-61. PubMed ID: 11501723
[TBL] [Abstract][Full Text] [Related]
45. Association of concomitant fibromyalgia with worse disease activity score in 28 joints, health assessment questionnaire, and short form 36 scores in patients with rheumatoid arthritis.
Ranzolin A; Brenol JC; Bredemeier M; Guarienti J; Rizzatti M; Feldman D; Xavier RM
Arthritis Rheum; 2009 Jun; 61(6):794-800. PubMed ID: 19479706
[TBL] [Abstract][Full Text] [Related]
46. Momentary relationship between cortisol secretion and symptoms in patients with fibromyalgia.
McLean SA; Williams DA; Harris RE; Kop WJ; Groner KH; Ambrose K; Lyden AK; Gracely RH; Crofford LJ; Geisser ME; Sen A; Biswas P; Clauw DJ
Arthritis Rheum; 2005 Nov; 52(11):3660-9. PubMed ID: 16258904
[TBL] [Abstract][Full Text] [Related]
47. Interrelations between fibromyalgia, thyroid autoantibodies, and depression.
Ribeiro LS; Proietti FA
J Rheumatol; 2004 Oct; 31(10):2036-40. PubMed ID: 15468372
[TBL] [Abstract][Full Text] [Related]
48. Affective pain modulation in fibromyalgia, somatoform pain disorder, back pain, and healthy controls.
Arnold BS; Alpers GW; Süss H; Friedel E; Kosmützky G; Geier A; Pauli P
Eur J Pain; 2008 Apr; 12(3):329-38. PubMed ID: 17723312
[TBL] [Abstract][Full Text] [Related]
49. Number of fibromyalgia tender points is associated with health status in patients with systemic lupus erythematosus.
Akkasilpa S; Goldman D; Magder LS; Petri M
J Rheumatol; 2005 Jan; 32(1):48-50. PubMed ID: 15630724
[TBL] [Abstract][Full Text] [Related]
50. Evaluation of the relationship between depression and fibromyalgia syndrome: why aren't all patients depressed?
Okifuji A; Turk DC; Sherman JJ
J Rheumatol; 2000 Jan; 27(1):212-9. PubMed ID: 10648041
[TBL] [Abstract][Full Text] [Related]
51. Osteopathic manipulative treatment in conjunction with medication relieves pain associated with fibromyalgia syndrome: results of a randomized clinical pilot project.
Gamber RG; Shores JH; Russo DP; Jimenez C; Rubin BR
J Am Osteopath Assoc; 2002 Jun; 102(6):321-5. PubMed ID: 12090649
[TBL] [Abstract][Full Text] [Related]
52. Stress perception and depressive symptoms: functionality and impact on the quality of life of women with fibromyalgia.
Homann D; Stefanello JM; Góes SM; Breda CA; Paiva Edos S; Leite N
Rev Bras Reumatol; 2012; 52(3):319-30. PubMed ID: 22641587
[TBL] [Abstract][Full Text] [Related]
53. Fibromyalgia: can one distinguish it from simulation? An observer-blind controlled study.
Khostanteen I; Tunks ER; Goldsmith CH; Ennis J
J Rheumatol; 2000 Nov; 27(11):2671-6. PubMed ID: 11093452
[TBL] [Abstract][Full Text] [Related]
54. Cyclic alternating pattern: a new marker of sleep alteration in patients with fibromyalgia?
Rizzi M; Sarzi-Puttini P; Atzeni F; Capsoni F; Andreoli A; Pecis M; Colombo S; Carrabba M; Sergi M
J Rheumatol; 2004 Jun; 31(6):1193-9. PubMed ID: 15170935
[TBL] [Abstract][Full Text] [Related]
55. Increased frequency of gastrointestinal symptoms in patients with fibromyalgia and associated factors: a comparative study.
Pamuk ON; Umit H; Harmandar O
J Rheumatol; 2009 Aug; 36(8):1720-4. PubMed ID: 19567625
[TBL] [Abstract][Full Text] [Related]
56. Increased BDNF serum concentration in fibromyalgia with or without depression or antidepressants.
Laske C; Stransky E; Eschweiler GW; Klein R; Wittorf A; Leyhe T; Richartz E; Köhler N; Bartels M; Buchkremer G; Schott K
J Psychiatr Res; 2007 Oct; 41(7):600-5. PubMed ID: 16600301
[TBL] [Abstract][Full Text] [Related]
57. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder.
Arnold LM; Lu Y; Crofford LJ; Wohlreich M; Detke MJ; Iyengar S; Goldstein DJ
Arthritis Rheum; 2004 Sep; 50(9):2974-84. PubMed ID: 15457467
[TBL] [Abstract][Full Text] [Related]
58. Hypothalamic-pituitary-gonadal axis and cortisol in young women with primary fibromyalgia: the potential roles of depression, fatigue, and sleep disturbance in the occurrence of hypocortisolism.
Gur A; Cevik R; Sarac AJ; Colpan L; Em S
Ann Rheum Dis; 2004 Nov; 63(11):1504-6. PubMed ID: 15479904
[TBL] [Abstract][Full Text] [Related]
59. Machine Learning to Understand the Immune-Inflammatory Pathways in Fibromyalgia.
Andrés-Rodríguez L; Borràs X; Feliu-Soler A; Pérez-Aranda A; Rozadilla-Sacanell A; Arranz B; Montero-Marin J; García-Campayo J; Angarita-Osorio N; Maes M; Luciano JV
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31470635
[TBL] [Abstract][Full Text] [Related]
60. Neurophysiologic evidence for a central sensitization in patients with fibromyalgia.
Desmeules JA; Cedraschi C; Rapiti E; Baumgartner E; Finckh A; Cohen P; Dayer P; Vischer TL
Arthritis Rheum; 2003 May; 48(5):1420-9. PubMed ID: 12746916
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
